Background and Aim: Hyperglycemia in type 1 diabetes (T1D) is accompanied by endothelial cell dysfunction which is known to contribute to the pathogenesis of cardiovascular disorders. The aim of the current study was to explore the profile of circulating endothelial progenitor cells (EPCs), circulating endothelial cells (CECs), endothelial and platelet derived micropaticles (EMPs, PMPs) and total microparticles (TMPs), in T1D children in relation to each other and to the metabolic disorders accompanying T1D. Patients and Methods: Thirty T1D patients and 20 age and sex matched healthy volunteers were assessed for HbA1c level and lipid profile. Quantification of CECs, EPCs, TMPs, EMPs and PMPs was done by flow cytometry. Results: The mean levels of EMPs, PMPs, TMPs and CECs were significantly higher in diabetic children compared to controls. Meanwhile, the levels of EPCs were significantly lower in diabetic children compared to controls. Both PMPs and CECs showed the highest significant differences between patients and controls and their levels were directly related to HbA1c, total cholesterol, LDL and triglycerides. A moderate correlation was observed between the frequency of PMPs and CECs. EPCs revealed negative correlations with both LDL and triglycerides. TMPs were only related to LDL, while EMPs were only related to HbA1c. Conclusion: Although there is disturbance in the levels of EMPs, PMPs, TMPs, CECs and EPCs in type 1 diabetic children compared to the controls, only the levels of PMPs and CECs were closely affected by the poor glycemic control and dyslipidemia occurring in T1D; thus may contribute to a higher risk of cardiovascular diseases.
Introduction
Diabetes mellitus is a chronic metabolic disease characterized by hyperglycemia with disorders in carbohydrate, protein, and lipid metabolism ultimately inducing chronic progressive damage of eyes, nerves, kidneys, heart, and blood vessels. 1 Hyperglycemia is associated with endothelial cell dysfunction and impaired neovascularization in response to tissue ischemia, 2 which are known to contribute to the pathogenesis of cardiovascular disorders (CVDs). 3 Thereby, investigating endothelium and searching for endothelial-derived noninvasive biomarkers of vascular dysfunction, including endothelialderived microparticles (EMPs), circulating endothelial cells (CECs), and circulating endothelial progenitors cells (EPCs), have gained growing interest. 4 Circulating endothelial cells are mature cells shed from the lining of blood vessels and are present in very low numbers in healthy individuals but are increased intensely in a variety of diseases with vascular damage in which their frequency are closely linked to the severity of vascular lesions. 5 Likewise, some elements such as vascular endothelial cells and circulating platelets release microsized particles (MPs) from the outward budding of plasma membranes in response to injurious stimuli and during cell apoptosis or activation. 6 These microparticles were found to be increased in a number of diseases associated with endothelial dysfunction and CVD. 7 On the other hand, circulating EPCs are bone marrow-derived cells that play important role in the vascular regeneration and neoangiogenesis. In addition, lower number of circulating EPCs was reported to be associated with increased risk of CVD. 8 Few studies have investigated the CECs, EPCs, EMPs, and platelet derived microparticles (PMPs) individually in type 1 diabetes (T1D) [9] [10] [11] ; therefore, the present work aims to explore the profile of these potential biomarkers in children with T1D in relation to each other and to the metabolic disorders accompanying T1D and posing vascular risk.
Patients and Methods

Study Population
This study was done in Assiut University Hospitals on 30 patients with T1D, diagnosed according to the criteria of American Diabetes Association for diagnosis of T1D, 12 presented to Pediatric Emergency Unit, Children Hospital, Faculty of Medicine, Assiut University, in the period from June 2017 to April 2018. Pediatric diabetic patients (age 18 years) were included. Patients with infection, other concurrent diseases, different age range or previously diagnosed as having type 2 diabetes (T2D) were excluded from the study. Additionally, 20 age-and sex-matched healthy volunteers were included as controls. The study was approved by the institutional review board of Assiut University, and informed written consents were taken from all guardians of cases and controls.
Baseline Investigations
All patients and controls were subjected to detailed history taking and physical examination. Evaluation of HbA 1c was performed by turbidimetric inhibition immunoassay using Hitachi autoanalyzer (Roch, Germany), and lipid profile was performed using Cobas Integra 400, automated chemical analyzer (S.N.: 500558; Roche Diagnostics GmbH, Mannheim, Germany). In addition, flow cytometry (FACSCalibur, Becton Dickinson [BD], San Jose, California) was used for characterization and quantification of MPs and detection of CECs and EPCs.
Flow Cytometric Analysis
Microparticles isolation and characterization. Citrated blood samples were used to isolate MPs within 15 minutes after collection. After centrifugation at 1550g for 20 minutes at 20 C, the cells were separated and 250 mL of plasma were centrifuged twice for 30 minutes at 18 800g at 20 C. The supernatant was discarded again and MPs pellet was resuspended in phosphatebuffered saline (PBS). Five microliter of MPs sample were diluted in 35-mL PBS containing 2.5 mM CaCl 2 and incubated 
Statistical Analysis
Statistical Package for Social Sciences, version 24.0 (IBM SPSS, Chicago, Illinois) was used for the statistical analysis. Results were expressed as mean (standard deviation). Student t test and w 2 test were used to compare continuous variables and categorical variables, respectively. Analysis of associations between the variables was done by the Pearson correlation coefficient. A P value was considered significant if less than .05.
Results
Clinical and Laboratory Characteristics of Study Population
In the study patients, the mean duration of T1D was 1.7 years. The mean levels of total cholesterol, low-density lipoprotein cholesterol (LDL), HDL cholesterol, and triglycerides were significantly higher in diabetic children compared to controls. Table 1 shows the clinical and laboratory characteristics of participants.
Complications were recorded in 9 children with history of T1D more than 5 years and higher HbA 1c levels than those with noncomplicated T1D. All were not on a regular insulin therapy. Hypertension was detected in 3 children, 2 had cerebrovascular stroke, 3 of them had impaired renal functions, and 1 had peripheral polyneuropathy.
Frequency of Microparticles, CECs, and Circulating EPCs
As shown in Table 2 , the mean levels of EMPs, PMPs, TMPs, and CECs were significantly higher in diabetic children compared to controls. Meanwhile, the levels of EPCs were significantly lower in diabetic children compared to controls.
Besides, several significant correlations were detected among the above tested parameters, as summarized in Table 3 . The PMPs have shown correlations with all other tested parameters. Moderate correlations were observed between the frequency of PMPs and each of CECs (positive correlation) and EPCs (negative correlation). Furthermore, a moderate negative correlation was found between the frequencies of EPCs and CECs.
Correlations of the Frequencies of Microparticles, CECs, and Circulating EPCs With Some Laboratory Findings Table 4 shows the relations between the frequencies of MPs, CECs, and circulating EPCs with some laboratory findings. Both PMPs and CECs showed significant positive correlations with HbA 1c , total cholesterol, LDL, and triglycerides. The EPCs have only revealed negative correlations with both LDL and triglycerides. The TMPs level was only related to LDL whereas EMPs level was only related to HbA 1c .
Discussion
Despite the higher risk of CVD observed in patients with T1D compared with T2D, 13, 14 few studies have individually investigated the CECs, EPCs, EMPs, and PMPs in T1D. [9] [10] [11] The ability to explore the endothelium using noninvasive approaches will aid better understanding of the pathology of CVD. By using multiple markers in assessing vascular competence, it would be possible to detect endothelial dysfunction at early preclinical stages, evaluate the vascular risk at later stages of CVD, and evaluate available therapeutic options. 4 Scarce data are available about the association of microparticles and T1D.
9,15 Levels of EMPs, PMPs, and TMPs were significantly higher in our children with T1D compared to healthy children, which comes in line with earlier studies in T2D 16, 17 and T1D 9,15 that considered these microparticles as early predictors of microvascular complications and subclinical atherosclerosis. The role played by MPs in the normal hemostasis in response to vascular injury and in CVD may be because they express procoagulant phospholipids, thereby increasing the risk of thromboembolic complications. 18, 19 Similar to previous studies, we found increased levels of CECs 11 and decreased levels of EPCs 10, [20] [21] [22] [23] [24] in children with T1D compared to healthy controls. On the contrary, only Głowińska-Olszewska and colleagues 25 have shown increased frequency of EPCs in children with T1D.
Both PMPs and CECs showed the highest significant differences between patients and controls compared to TMPS, EMPS, and EPCs. In addition, they have shown direct relations with HbA 1c , total cholesterol, LDL, and triglycerides, unlike EPCs which have revealed negative correlations with both LDL and triglycerides. The TMPs were only related to LDL and EMPs were only related to HbA 1c . A moderate correlation was also observed between the frequency of PMPs and CECs. These results may indicate that the levels of PMPs and CECs are closely affected by the poor glycemic control and dyslipidemia occurring in T1D and may contribute to a higher risk of CVD. Consequently, they together may represent good integrative potential biomarkers for endothelial dysfunction, vascular incompetence, and increased procoagulant activity. Worth mentioning, CECs showed stronger correlations with HbA 1c and parameters of the lipid profile compared to PMPs. Likewise, some previous studies reported positive correlations between HbA 1c and each of CECs 11 and microparticles. 9, 26 Taniyama and Griendling 27 proposed that the mechanism by which the frequency of CECs increases in children with T1D may be related to hyperglycemia which enhances oxidative stress and increases sloughing of endothelial cells. On the contrary, an earlier study 28 did not find the increase in CECs to be related to HbA 1c in patients with T2D and suggested that even with the control of blood glucose levels, endothelial cell shedding will probably not decrease.
Prior clinical studies have shown conflicting results regarding the relation between the levels of EPCs and HbA 1c . While Arcangeli et al, 10 in agreement with our results, didn't find a relation between their levels, other studies 20, 21 found the level of EPCs to be inversely associated with HbA 1c .
In this study, the positive correlations detected between PMPs and CECs in relation to LDL and triglycerides levels may explain the role of LDL and triglycerides in initiating atherosclerosis, through increasing the level of microparticles and CECs that promotes endothelial dysfunction and inflammation of arterial wall. 29, 30 Also, the finding of negative correlations between the level of EPCs and each of LDL and triglycerides was in line with a previous study, 31 which concluded that LDL impairs EPCs function, at least partly, by causing oxidative stress and activating NF-kB pathway and hence ruins host repair of endothelial injury. 
Conclusion
Although there is disturbance in the levels of EMPs, PMPs, TMPs, CECs, and EPCs in T1 diabetic children compared to controls, only the levels of PMPs and CECs are closely affected by the poor glycemic control and dyslipidemia occurring in T1D and thus may contribute to a higher risk of CVD.
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